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Abstract
Comprehensive determination of the microbial composition of the gut microbiota and the relationships with health and disease are
major challenges in the 21st century. Metagenomic analysis of the human gut microbiota detects mostly uncultured bacteria. We studied
stools from two lean Africans and one obese European, using 212 different culture conditions (microbial culturomics), and tested the
colonies by using mass spectrometry and 16S rRNA amplification and sequencing. In parallel, we analysed the same three samples by
pyrosequencing 16S rRNA amplicons targeting the V6 region. The 32 500 colonies obtained by culturomics have yielded 340 species of
bacteria from seven phyla and 117 genera, including two species from rare phyla (Deinococcus-Thermus and Synergistetes, five fungi, and a
giant virus (Senegalvirus). The microbiome identified by culturomics included 174 species never described previously in the human gut,
including 31 new species and genera for which the genomes were sequenced, generating c. 10 000 new unknown genes (ORFans), which
will help in future molecular studies. Among these, the new species Microvirga massiliensis has the largest bacterial genome so far
obtained from a human, and Senegalvirus is the largest virus reported in the human gut. Concurrent metagenomic analysis of the same
samples produced 698 phylotypes, including 282 known species, 51 of which overlapped with the microbiome identified by culturomics.
Thus, culturomics complements metagenomics by overcoming the depth bias inherent in metagenomic approaches.
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Introduction
The composition of the human gut microbiome, the determina-
tion of which represents a major challenge in the 21st century
[1], has been studied with different tools, leading to increasingly
complex results [2–6]. The first approach used to study the gut
microbiota employed microbial culture [2]. Subsequent studies
that involved amplification and sequencing of 16S rRNA and later
metagenomic analysis have dramatically expanded the known
diversity of the human gut microbiome [4,5,7,8]. It is commonly
accepted that c. 80% of the bacterial species found by molecular
tools in the human gut are uncultured or even unculturable [1].
However, several drawbacks of the current metagenomic
approaches, including major discrepancies among different
studies, apparently reflect biases of the employed techniques. In
particular, sequence-based techniques miss clinically relevant
minority populations, including potentially pathogenic bacteria,
such as Salmonella Typhi, Tropheryma whipplei, and Yersinia
enterocolitica, that may be present at concentrations lower than
105/mL; this major problem is known as the depth bias.
Recently, there has been a renewed interest in culture
methods for ‘non-cultivable’ species [3,9]. One of the grid-
locks of the traditional bacteriological culture methods has
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been recently overcome by advances in mass spectrometry
(MS) techniques, which can accurately and rapidly identify
microorganisms with matrix-assisted laser desorption ioniza-
tion time-of-flight (MALDI-TOF), allowing rapid screening of
large numbers of colonies [10]. In this study, we combined
the MS approach with extensive sequencing and exploration
of the potential of numerous known and new culture meth-
ods to introduce culturomics as a major complement to me-
tagenomics in the study of the human gut microbiome.
Materials and Methods
All of the data are detailed in the Supporting information. We
used two African stools, both from healthy young males living in
rural Senegal, and a stool from a French obese individual with a
body mass index of 48.2 kg/m2. Each patient’s consent was
obtained, and the study was approved by the local ethics commit-
tee of IFR48 (agreement number 09-022; Marseille, France). We
designed 212 culture conditions, using variable physicochemical
conditions, pre-incubation in blood culture bottles, rumen fluid
and sterile stool extract to mimic the natural environment [9].
Moreover, with the aim of selecting a minority population, we
used antibiotics, both active and passive filtration, and bacterio-
phages. We used MALDI-TOF MS to quickly identify a maximum
of colonies. When the strains remained unrecognized, the 16S
rRNA gene was sequenced. As previously described, a threshold
similarity of >98.7% was chosen to define a new bacterial species
[11]. The same three stool samples were tested by pyrosequenc-
ing of a 16S rRNA amplicon targeting the V6 region, the most
variable region, as previously described [7] NCBI accession num-
ber=SRA049748. The new bacterial genera and species were
sequenced with a paired-end strategy for high-throughput
pyrosequencing on the 454-Titanium instrument. Senegalvirus
was sequenced with the Roche 454 FLX-Titanium platform.
Results
Proof-of-concept
We studied stool samples from two young lean Africans
from a rural environment in Senegal (Fig. 1) and one obese
(a)
(b)
(c)
(d)
FIG. 1. The source of material for culturomics and the record-breaking virus and bacterium from the human gut. (a) The geographical locations
of the Dielmo and N’diop villages (Sources: Wikitravel.org and Google Earth) from which the two African stool samples analysed in this work
were obtained. (b) Electronmicrograph of the giant Senegalvirus, which was isolated from a stool sample of an individual from N’Diop. (c)
Comparison of the Senegalvirus genome with the genomes of related giant viruses, Marseillevirus and Lausannevirus. (d) Electronmicrograph of
Microvirga massiliensis (the bacterium with the largest genome ever isolated from humans), which was isolated from the Dielmo stool sample.
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French individual, using 212 different conditions, including
amoebal co-culture. For the first African sample, 56 different
culture methods were applied, including different physico-
chemical conditions and the addition of specific nutrients or
inhibitors (Table S1). Using these approaches, we isolated
3000 colonies, which were subjected to MALDI-TOF MS
analysis for rapid identification of microbial species [10]. This
analysis resulted in the identification of 99 bacterial species,
42 of which had never been found in the human gut
(Fig. S1), and two of which had never been described
(Table 1 Fig. 2).
With the two other stool samples, only those culture
conditions that proved to be efficient with the first sample
were used again, and many additional culture conditions
were applied to maximize the chance of isolation of new
species (Table S1). This optimized approach yielded 191 dis-
tinct bacterial isolates, including two new genera and six new
species from the obese individual’s stool sample; the largest
number of bacteria ever identified in a single stool (219 bac-
teria and five fungi, including three new genera and 18 new
bacterial species) were isolated from the second African
sample (Tables 1 and 2; Fig. 2; Table S2) [12–16].
TABLE 1. Characteristics of the 23 new bacterial species and genera cultured from the Senegalese stools [12–16]
Phylum Initial culture conditions
Diameter
(lm) (EM)
Genome size
estimate (Mb)
ORFan
(%)
Estimated GC
content (%)
Genbank
no.
N’Diop stool sample
New species
Oceanobacillus massiliensis Firmicutes Filtration brain–heart infusion 5% sheep
blood 0.45-lm aerobe, 37C
0.70 3.6 5.6 41 HQ586877
Bacillus timonensis Firmicutes Brain–heart infusion + sheep blood 5%,
aerobe, 37C
0.66 4.7 6.8 38.3 JF824810
Dielmo stool sample
New species
Kurthia massiliensis Firmicutes CNA aerobe 2.5% CO2, 37C 1.08 3.3 11.9 39.7 JF824795
Kurthia senegalensis Firmicutes Filtration 5% sheep blood agar 1.2-lm
aerobe, 37C
1.03 2.9 11.3 39.6 JF824796
Kurthia timonensis Firmicutes HTM, aerobe, 2.5% CO2, 37C 0.94 4.1 16.2 39 JF824797
Anaerococcus senegalensis Firmicutes Brucella anaerobe, 37C 0.68 1.8 3 28.5 JF824805
Paenibacillus senegalensis Firmicutes Schaedler kanamycin vancomycin, aerobe,
37C
0.66 5.7 10.7 48.3 JF824808
Bacillus massiliosenegalensis Firmicutes 5% sheep blood agar, aerobe, 28C 0.64 4.9 7.7 37.7 JF824800
Clostridium senegalense Firmicutes Inoculation in blood culture bottle for
5 days with 5 mL of sheep blood, 5%
sheep blood agar, anaerobe, 37C
1.05 3.9 11.5 29.3 JF824801
Peptoniphilus senegalensis Firmicutes Inoculation in blood culture bottle for
10 days with 5 mL of sheep blood,
5% sheep blood agar, anaerobe, 37C
0.64 1.8 3.9 32.5 JF824803
Peptoniphilus timonensis Firmicutes Inoculation in blood culture bottle anaerobe
for 14 days with 8 mL of rumen fluid, 5%
sheep blood agar, anaerobe, 37C
0.91 1.7 9.3 31 JN657222
Ruminococcus massiliensisa Firmicutes Inoculation in blood culture bottle anaerobe
for 14 days with 8 mL of rumen fluid 5%
sheep blood agar, anaerobe, 37C
0.96 5.1 25 57 JN657221
Alistipes senegalensis Bacteroidetes Schaedler kanamycin vancomycin, anaerobe,
37C
0.53 4 3.8 58.3 JF824804
Alistipes timonensis Bacteroidetes Inoculation in blood culture bottle anaerobe
for 5 days, Schaedler kanamycin
vancomycin, anaerobe 37C
0.62 3.5 2.9 58.8 JF824799
Cellulomonas massiliensis Actinobacteria Passive filtration with Leptospira broth, 5%
sheep blood agar, aerobic atmosphere,
37C
0.48 3.4 7.9 73.9 JN657218
Aeromicrobium massiliense Actinobacteria 5% sheep blood agar, aerobe, 37C 1.04 3.3 10.5 72.6 JF824798
Brevibacterium senegalense Actinobacteria Brucella, aerobe, 37C 0.68 3.4 9.6 69.9 JF824806
Enterobacter massiliensis Proteobacteria Phage T1 + T4, then 5% sheep blood agar,
aerobe, 37C
1.02 4.9 3 55.4 JN657217
Herbaspirillum massiliense Proteobacteria Passive filtration with Leptospira broth, 5%
sheep blood agar, aerobic atmosphere,
37C
0.44 4.2 8.1 59.7 JN657219
Microvirga massiliensis Proteobacteria MOD 2, aerobe, 37C 2.28 9.35 24.1 59.2 JF824802
New genera
Dielma fastidiosa Firmicutes Inoculation in blood culture bottle anaerobe
for 10 days, brain–heart infusion, anaerobe,
37C
0.59 3.6 10.5 40 JF824807
Senegalemassilia anaerobia Actinobacteria Inoculation in blood culture bottle anaerobe
for 5 days. 5% sheep blood aga,r anaerobe,
37C
0.70 2.3 6.3 61.8 JF824809
Timonella senegalensis Actinobacteria Inoculation in blood culture bottle anaerobe
for 14 days with 8 mL of rumen fluid, 5%
sheep blood agar, anaerobe, 37C
0.59 3 11.9 61.3 JN657220
EM : Electron Microscopy.
aThe characterization of this bacterial species was not performed, because the impossibility of subculture.
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TABLE 2. Characteristics of the eight new bacterial species and genera cultured from the stools of the obese individual
Phylum Initial culture conditions
Diameter
(lm) (EM)
Genome size
estimate (Mb)
ORFan
(%)
Estimated GC
content (%)
Genbank
no.
New species
Anaerococcus obesiensis Firmicutes Inoculation in blood culture bottle with
thioglycolate for 4 days, 5% sheep blood
agar, anaerobe, 37C
0.71 2.05 3.7 30.1 JN837490
Brevibacillus massiliensis Firmicutes M17, aerobe, 37C 0.73 5.1 7.2 53 JN837488
Peptoniphilus grossensis Firmicutes Inoculation in blood culture bottle for
26 days with rumen and sheep blood, 5%
sheep blood agar, anaerobe, 37C
0.77 2.1 5.5 34.5 JN837491
Peptoniphilus obesiensis Firmicutes Inoculation in blood culture bottle for
26 days with rumen and sheep blood, 5%
sheep blood agar, anaerobe, 37C
0.85 1.77 4.7 30.4 JN837495
Alistipes obesiensis Bacteroidetes Inoculation in blood culture bottle for
11 days with rumen, 5% sheep blood agar,
anaerobe, 37C
0.61 3.1 7.3 58.5 JN837494
Actinomyces grossensis Actinobacteria Inoculation in blood culture bottle with
thioglycolate for 4 days, 5% sheep blood
agar, anaerobe, 37C
0.49 1.87 5.2 56 JN837492
New genera
Enorma massiliensis Actinobacteria Inoculation in blood culture bottle with
thioglycolate for 4 days, 5% sheep blood
agar, anaerobe, 37C
0.57 2.3 7.9 61.8 JN837493
Kallipyga massiliensis Firmicutes Inoculation in blood culture bottle for
26 days with rumen and sheep blood, 5%
sheep blood agar, anaerobe, 37C
0.67 1.77 6.3 51.4 JN837487
EM : Electron Microscopy.
FIG. 2. Phylogenetic tree representing the new bacterial species and genera obtained by culturomics. Red labels indicate the new species found
in the Senegalese patients and obese patient. Dark labels indicate the closest neighbour species defined as Isolates and Type in the RDP-II
database. Tree branches in red, dark green, purple and blue represent the phyla Bacteroidetes, Proteobacteria, Actinobacteria, and Firmicutes,
respectively. Green squares denote new species found in the obese patient. Dark circles indicate that the genome sequence is available for the
closest neighbour species.
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Optimization of rapid screening by MALDI-TOF MS
With a low level of operator training, MALDI-TOF MS allows
rapid discrimination between identified bacteria (present in the
current data bank) and unidentified bacteria. Indeed, subsequent
to the analysis of the first sample, with the two other tested
samples we were able to identify a significantly greater number
of colonies: without automatic colony picking, we tested a total
of 29 500 different colonies from these two samples, as com-
pared with the 3000 colonies tested from the first sample. In
addition to the better training of the operators, as and when
necessary, each previously unknown bacterial spectrum was
added to our data bank, facilitating the screening for further
studies. MS, which obviates the need for both the time-consum-
ing Gram-staining procedure and the usual biochemical tests,
seems to be the current method of choice for the identification
of microorganisms, and has the potential to supplant traditional
microbiological methods [10]. Indeed, with the third stool sam-
ple, we tested, under eight different culture conditions, 50–100
colonies that were indistinguishable in appearance. This experi-
ment allowed us to identify several species, notably those from
the genus Enterococcus, for which identification in routine bacte-
riology is mainly based on colony morphology.
Eliminating the predominant population
The high concentration of bacteria in the human gut (1012 to
1011 bacteria per gram of stools) [1] hampers non-selective
culture analysis. Therefore, we used antibiotics in culture
media to eliminate sensitive organisms and thus facilitate the
identification of resistant ones. We developed different strate-
gies to extend the use of ‘classic selective media’. First, to
identify new proteobacteria, we had to develop alternative
strategies, because Escherichia coli is the overwhelmingly domi-
nant bacterial species in the human gut under aerobic condi-
tions. We used a cocktail of E. coli lytic bacteriophages [17]
that allowed us to clear the culture of E. coli and to identify
an unknown enterobacterial species (Enterobacter massiliensis)
that was not detected by classic axenic culture.
Otherwise, an effective method to remove the major bac-
terial population was active filtration with successive mem-
branes (from 5 to 0.2 lm); this procedure allowed us to
identify eight new bacterial species. Finally, using the physical
characteristics of certain bacteria, we applied passive filtration,
which resulted in the identification, in the second African
stool sample, of three motile bacteria that have not been pre-
viously detected in the human gut, including two new species
(Table 1 and Table S1).
Enrichment of samples in blood culture bottles
Incubation of clinical samples in blood culture bottles is
known to promote the growth of Kingella kingae in osteoar-
ticular infections. Therefore, for the second and the third
samples, we developed an enrichment culture technique
involving several days of direct pre-incubation of stools in an
aerobic or anaerobic blood culture bottle, allowing the
growth of 29 bacterial species that were not detected by
standard axenic culture (including 24 anaerobic species). This
approach yielded three new genera and three new species.
Addition of sheep blood to the blood culture bottle allowed
us to identify three additional species.
New culture conditions
To increase the growth of bacteria under culture conditions
that mimic their natural environment, and drawing from pre-
vious studies on environmental bacteria [9], we used sterile
rumen fluid [3] (Fig. S2) and sterile fresh human stools with
or without pre-incubation in blood culture bottles. This
approach allowed us to isolate 17 strains that were not
recovered in classic axenic conditions, including two new
genera, three new species, and one species of the Deinococ-
cus-Thermus phylum that has not been previously cultured
from human clinical samples [18].
Finally, in an effort to obtain fastidious bacteria by amoe-
bal co-culture with Acanthamoeba polyphaga [19], we identi-
fied from the three stool samples four additional bacterial
species that have not been detected by axenic culture. Ser-
endipitously, we also isolated, from the first African stool, a
new giant virus strain, which we named Senegalvirus and that
has the largest genome among the viruses isolated from
humans (Figs 1 and S3), with the exception of two reports
of mimivirus detection [19]. The isolation of a non-filterable
giant virus from a human stool indicates that giant viruses
could constitute a component of the gut microbiome that is
missed by metagenomic studies with 0.22-lm filters [6,20].
Microbial culturomics: a general perspective
Only 45 bacterial species obtained in culture in the present
work were common to all three analysed stool samples and
could be named ‘the culturomics core microbiome’. The
majority of the isolated species (63.6%) were cultured from
only one stool sample, indicative of large inter-individual
diversity of the human gut microbiome (Fig. S4). Thus,
microbial culturomics allowed the detection of numerous
new bacteria from each tested sample (Tables 1 and 2).
Although we used a total of 212 different culture condi-
tions for the three stool samples, 100% of the species
grew under only 70 culture conditions, and 73% of the
species were identified with only 20 conditions (Fig. S5;
Table S3). These results provide guidance for future cul-
turomics studies, which will benefit from using the set of
conditions shown to be efficient in this study before
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developing new culture approaches. Although a limited
number of culture conditions allowed us to grow the
majority of the common bacterial species, a more thor-
ough approach that used many ‘exotic’ culture conditions
substantially expanded the repertoire by allowing the isola-
tion of less abundant bacteria.
‘Giant’ bacteria and giant virus
The typical diameter of the isolated bacteria ranged from 0.5
to 1.5 lm [21]. However, the largest isolated bacterium, Mi-
crovirga massiliensis, reached 2.28 lm according to transmis-
sion electron microscopy, and was also shown to possess
the largest genome (9.35 Mb) of any bacterium previously
obtained from a human sample (Tables 1 and 2; Fig. 1). The
giant (194 nm in diameter) Senegalvirus isolated by amoebal
co-culture is the first giant virus ever isolated from the
human gut. The genome of Senegalvirus (Genbank JF909596–
JF909602) is closely related to those of Marseillevirus (96%
identity) and Lausannevirus [22] (Fig. S3), suggesting that this
is a new strain of Marseillevirus. Preliminary work indicates
the presence of antibodies against this virus in the serum
and stool of the subject.
Genome sequencing of new bacteria
The genomes of all 31 new bacterial species and genera
(Tables 1 and 2; Fig. 2) isolated from the two African stool
samples and the French stool sample were sequenced, gener-
ating a total of 110.4 Mb of unique sequence, and are freely
available in the EMBL database (http://www.ebi.ac.uk/embl/
Submission/index.html). The genome sizes of the new bacte-
ria ranged from 1.7 to 9.35 Mb. Among the predicted gene
products of the new genomes, 2.9–24.1% had no readily
detectable homologues, i.e. they represented ORFans. Alto-
gether, the present study yielded c. 10 000 previously
unknown genes.
Comparison with 16S rRNA sequencing
The pyrosequencing that was performed as part of this
study identified 126, 138 and 157 phylotypes correspond-
ing to known species from the three stools, respectively
(Tables S4, S5 and S6). For the three stools taken
together, the microbial culturomics approach yielded 340
bacterial species from seven phyla and 117 genera,
whereas pyrosequencing identified 282 species from six
phyla and 91 genera. However, a dramatic difference was
observed with culturomics: only 51 phylotypes were com-
mon between the two approaches (15% of the culturomics
set) (Fig. 3a). Among the ‘culturomics core microbiome’ of
45 cultured species, only 12 (26%) were detected by py-
rosequencing. Similarly, only 44 genera (38% of the cul-
turomics set) were shared between the two approaches
(Fig. 3b). Altogether, 416 phylotypes of previously uncul-
tured bacteria were identified. Notably, the sequence from
a new genus cultured here (Senegalemassilia anaerobia) had
been previously identified as an uncultured bacterium by
metagenomics, demonstrating the capacity of culturomics
to grow such supposedly ‘unculturable’ microorganisms
[23–27]. Finally, the molecular techniques did not identify
pathogenic bacteria, such as Salmonella, that were detected
by culturomics (Fig. 4).
(a) (b)
FIG. 3. Identification of bacteria in the human gut by culturomics and metagenomics. (a) The two ‘icebergs’ represent the 340 cultured bacterial
species and the 698 phylotypes identified by pyrosequencing. The overlap between the two sets of species, i.e. the 51 species detected by both
approaches, is shown in purple. Below the ‘sea level’ is the projected unknown part of the human gut microbiome. (b) Taxonomic distribution
of organisms identified by culturomics and pyrosequencing. The ovoid shape denoted ‘Culture’ indicates all of the bacterial and fungal genera
identified by culturomics from the three stool samples. The ovoid shape denoted ‘Pyro’ indicates genera identified by 16S amplicon pyrosequenc-
ing of the three stool samples. The dashed coloured lines show the phylum membership of the respective genus node. The two shapes with
dashed lines at left and right represent the bacterial and fungal genera identified by only one technique (pyrosequencing or culturomics), whereas
the shape in the middle represents the genera identified by both culturomics and pyrosequencing.
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Discussion
Metagenomics is currently thought of as the mainstream of
microbiome studies, in particular as applied to the human
gut. Unexpectedly, however, in a direct comparison, we
described more known bacterial species by systematically
applying a large sample of culture conditions (the approach
we denoted culturomics) than by pyrosequencing (Fig. 3a).
Moreover, we found a dramatic divergence between the sets
of bacteria identified by the two approaches at the level of
both species and genera. The detection by culturomics of
numerous bacteria that go undetected in genomic and me-
tagenomic studies is far from being trivial, even if most of
these microorganisms are of low abundance. Undoubtedly, a
minority population, as in the famous short story [28], can
have a substantial effect on the ecology of the gut microbiota
and on human health. Indeed, c. 65% of bacterial species
from the three samples were detected at concentrations
between 103 and 106 CFU/mL, which are below the
detection thresholds of large-scale molecular studies, demon-
strating the major ‘depth bias’ that is characteristic of the
metagenomic approaches (Fig. 4). In support of this conclusion,
culture methods allowed the detection of Staphylococcus aur-
eus that was added to the stools at a concentration that was
100 times lower than the concentration detectable by molec-
ular tools (Fig. 4).
The paradigm shift in microbiome study that seems to be
brought about by culturomics became possible thanks to the
breakthrough in the application of MALDI-TOF MS [10]. In
comparison with the most rapid conventional phenotypic
identification method for bacteria (Vitek System; Biomerieux,
Marcy I’Etoile, France), MALDI-TOF MS reduces by c. 55-fold
the time to bacterial identification and reduces the costs by
at least a factor of 5 [10]. Therefore, MALDI-TOF MS is cur-
rently the most time-effective and cost-effective identification
method available for culture-based microbiota studies.
In the present culturomics study, the actual analysis of
microbial cultures involved only three students (JCL,MM,PH)
that performed the experience on the three stools during
2 years in a single laboratory. Nevertheless, this limited effort
yielded 174 bacterial species that have not been previously
reported from the human gut microbiota. Genome sequencing
of these bacteria would increase by c. 18% the number of
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sequenced bacterial genomes from the human gut (975) that
have been identified by several laboratories within the human
microbiome project [29].
The present limited culturomics study shows that microbial
biodiversity in the human gut is substantially broader than pre-
dicted on the basis of genomic and metagenomic analyses
[27,30]. Interestingly, culturomics also ‘broke the records’ for
the largest bacterium and virus isolated from humans so far.
By using different atmospheres, temperatures, pH, nutrients,
minerals, antibiotics or phages, ‘microbial culturomics’ pro-
vides comprehensive culture conditions simulating, reproduc-
ing or mimicking the entirety of selective constraints that have
shaped the gut microbiota for millions of years. In fact, each
isolated microorganism is one among the possible viable solu-
tions to the evolutionary equation whose constants are the
selective constraints of the environment, corresponding here
to the human gut. This is why microbial culturomics is the best
way to capture the functional and viable gut microbiota biodi-
versity of each human individual through large-scale isolation,
and to capture the deepest informational genetic gut biodiver-
sity by sequencing the complete genomes of the previously iso-
lated microorganisms. In the future, the use of the most
effective conditions and automatic colony picking will further
deepen this field of research.
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